Federal Register of Legislation - Australian Government

Primary content

PB 119 of 2022 Determinations/Health as made
The instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 by adding various forms of amoxicillin that are currently subject to a Therapeutic Goods Administration (TGA) Serious Scarcity Substitution Instrument (SSSI). This allows supplies made under the TGA SSSI to be Pharmaceutical Benefits Scheme subsidised.
Administered by: Health and Aged Care
Registered 05 Dec 2022
Tabling HistoryDate
Tabled HR15-Dec-2022
Tabled Senate06-Feb-2023
Date of repeal 30 Mar 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Enabled by
Authoritative version National Health Act 1953
C1953A00095No. 95, 1953